Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

25-02-2020 | Renal cell carcinoma | Conference coverage | Video

Metastatic RCC updates from ASCO GU 2020

Speakers: Bernard Escudier and Viktor Grünwald

Bernard Escudier and Viktor Grünwald take us through the metastatic renal cell carcinoma studies that caught their attention at the 2020 Genitourinary Cancers Symposium, including long-term data from the CheckMate 214 trial and studies of novel agents such as the HIF-2α inhibitor MK-6482 and sitravatinib.

This independent video was supported by an educational grant from Pfizer and Merck KGaA.

External Content

Click Play to display this content and agree to third party cookies. (>)

Update your current cookie settings.

Related content

02-03-2020 | ASCO GU 2020 | Conference coverage | News

Updated CheckMate 214 analysis confirms nivolumab–ipilimumab RCC benefit

27-02-2020 | ASCO GU 2020 | Conference coverage | News

Sitravatinib may boost nivolumab efficacy in advanced clear-cell RCC

28-02-2020 | ASCO GU 2020 | Conference coverage | News

Drug targeting HIF-2α ‘well-tolerated’ in advanced clear-cell RCC

15-02-2020 | ASCO GU 2020 | Conference coverage | Video

Researcher comment: HIF-2α inhibition in RCC
  • » This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

ASCO GU 2020 conference hub

ASCO GU 2020 conference hub

Access all the latest news and expert video commentary from the 2020 Genitourinary Cancers Symposium in San Francisco, USA.

Register for conference alerts

Receive the latest content direct to your inbox.

Image Credits